drugset / Trial / NCT03427359

Induction Cisplatin and Capecitabine Followed by Concurrent Chemoradiotherapy for Nasopharyngeal Carcinoma

NCT03427359 ↗

Phase 2 Completed 65 enrolled The University of Hong Kong-Shenzhen Hospital
NaSingle-groupOpen-labelTreatment

Summary

To prospectively evaluate the short-term efficacy and toxicity of induction chemotherapy with cisplatin and capecitabine followed by concurrent chemoradiotherapy (CCRT) in the treatment of locally advanced nasopharyngeal carcinoma.

Timeline

Start
2015-01-22
Primary completion
2017-12-31
Completion
2017-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Capecitabine Small molecule 1000 mg/m2 Oral
Subject Cisplatin Other / unclassified 100 mg/m2 Intravenous